Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private ...
BAT's additional investment in Organigram is a strategic reinforcement to Organigram's strategic plan amidst financial strain. Amid Organigram's challenges, including regulatory uncertainties and ...
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a C$124.6 million ...
OrganiGram’s stock rose 4.24% to $1.23 on May 12, 2025, reflecting positive market sentiment following the company’s strong quarterly results. The presentation highlights OrganiGram’s 12-year journey ...
TORONTO--(BUSINESS WIRE)-- Organigram Global Inc. (“Organigram” or the “Company”) announces that Ms. Beena Goldenberg will extend her tenure as Chief Executive Officer until November 30, 2025 to ...
OrganiGram reported exceptional financial results for Q3 2025, with record gross revenue of $110.2 million, representing a 73% year-over-year increase and a 7.2% sequential improvement. Net revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback